Skip to main content
Year archive

Kintor Pharmaceutical Limited — 2020 filings

All 43 regulatory filings released by Kintor Pharmaceutical Limited (9939) in 2020, sourced directly from the official regulator.

43 Filings
2020 Period
2020 filings (43)
Filing Released Lang
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENTS ENROLMENT FOR PYRILUTAMIDE (KX-826)'S PHASE II CLINICAL TRIAL FOR INDICATION OF ANDROGENETIC ALOPECIA IN THE PRC
Regulatory Filings
2020-12-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-12-29 English
RESIGNATION OF DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES
Board/Management Information
2020-12-29 English
VOLUNTARY ANNOUNCEMENT PRELIMINARY RESULTS FROM THE CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF COVID-19
Regulatory Filings
2020-12-11 English
KINTOR TO PRESENT RESULTS OF GT90001 AND OPDIVO COMBO STUDY AT 2021 ASCO GI
Regulatory Filings
2020-12-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Major Shareholding Notification
2020-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Regulatory Filings
2020-11-02 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-10-27 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-10-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Capital/Financing Update
2020-10-05 English
ANNOUNCEMENT INSIDE INFORMATION PROGRESS OF PROXALUTAMIDE MONOTHERAPY PHASE III CLINICAL TRIALS IN CHINA
Regulatory Filings
2020-09-28 English
INTERIM REPORT 2020
Interim / Quarterly Report
2020-09-25 English
VOLUNTARY ANNOUNCEMENT PYRILUTAMIDE (KX-826) OBTAINED INVESTIGATIONAL NEW DRUG (IND) APPLICATION APPROVAL FROM NMPA FOR ACNE VULGARIS IN CHINA
Regulatory Filings
2020-09-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Regulatory Filings
2020-09-03 English
Clarification Announcement
Regulatory Filings
2020-08-23 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
Interim / Quarterly Report
2020-08-21 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLMENT FOR THE COVID-19 STUDY OF PROXALUTAMIDE WITH APPLIED BIOLOGY
Regulatory Filings
2020-08-21 English
VOLUNTARY ANNOUNCEMENT LICENSING OF PD-L1 AND TGF-B WITH GENSUN
Capital/Financing Update
2020-08-20 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-11 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENTS ENROLMENT FOR PROXALUTAMIDE PHASE III REGISTRATION CLINICAL TRIALS
Regulatory Filings
2020-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Share Issue/Capital Change
2020-08-04 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PHASE Ib CLINICAL TRIALS OF PYRILUTAMIDE (KX-826) IN THE UNITED STATES
Regulatory Filings
2020-08-04 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENTS ENROLMENT FOR PROXALUTAMIDE PHASE II CLINICAL TRIALS IN THE UNITED STATES
Regulatory Filings
2020-07-19 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-07-17 English
RESIGNATION AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-07-17 English
VOLUNTARY ANNOUNCEMENT CLINICAL TRIAL COLLABORATION IN COVID-19 STUDY OF PROXALUTAMIDE
Regulatory Filings
2020-07-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Regulatory Filings
2020-07-07 English
VOLUNTARY ANNOUNCEMENT FRAMEWORK AGREEMENT WITH JD HEALTHCARE
Regulatory Filings
2020-06-28 English
LAPSE OF OVER-ALLOTMENT OPTION, STABILISATION ACTIONS AND END OF STABILISATION PERIOD
Capital/Financing Update
2020-06-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Regulatory Filings
2020-06-03 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2020-05-21 English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Remuneration Information
2020-05-21 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
Governance Information
2020-05-21 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information
2020-05-21 English
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2020-05-21 English
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
Regulatory Filings
2020-05-21 English
GREEN APPLICATION FORM
Capital/Financing Update
2020-05-12 English
YELLOW APPLICATION FORM
Share Issue/Capital Change
2020-05-12 English
WHITE APPLICATION FORM
Capital/Financing Update
2020-05-12 English
GLOBAL OFFERING
Share Issue/Capital Change
2020-05-12 English
GLOBAL OFFERING
Capital/Financing Update
2020-05-12 English
PHIP (1st submission)
Regulatory Filings
2020-04-26 English
PHIP (1st submission)
Regulatory Filings
2020-04-26 English